Sun L - Search Results

1

Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design.

Sun L, Vasilevich NI, Fuselier JA, Hocart SJ, Coy DH. Sun L, et al. Bioorg Med Chem Lett. 2004 May 3;14(9):2041-6. doi: 10.1016/j.bmcl.2004.02.050. Bioorg Med Chem Lett. 2004. PMID: 15080975

2

Antisense peptide nucleic acids conjugated to somatostatin analogs and targeted at the n-myc oncogene display enhanced cytotoxity to human neuroblastoma IMR32 cells expressing somatostatin receptors.

Sun L, Fuselier JA, Murphy WA, Coy DH. Sun L, et al. Peptides. 2002 Sep;23(9):1557-65. doi: 10.1016/s0196-9781(02)00096-7. Peptides. 2002. PMID: 12217415

3

An adjustable release rate linking strategy for cytotoxin-peptide conjugates.

Fuselier JA, Sun L, Woltering SN, Murphy WA, Vasilevich N, Coy DH. Fuselier JA, et al. Among authors: sun l. Bioorg Med Chem Lett. 2003 Mar 10;13(5):799-803. doi: 10.1016/s0960-894x(03)00016-7. Bioorg Med Chem Lett. 2003. PMID: 12617894

4

Abilities of 3,4-diarylfuran-2-one analogs of combretastatin A-4 to inhibit both proliferation of tumor cell lines and growth of relevant tumors in nude mice.

Sun L, Vasilevich NI, Fuselier JA, Coy DH. Sun L, et al. Anticancer Res. 2004 Jan-Feb;24(1):179-86. Anticancer Res. 2004. PMID: 15015595 Free article.

5

Effects of camptothecin conjugated to a somatostatin analog vector on growth of tumor cell lines in culture and related tumors in rodents.

Sun L, Fuselier JA, Coy DH. Sun L, et al. Drug Deliv. 2004 Jul-Aug;11(4):231-8. doi: 10.1080/10717540490446125. Drug Deliv. 2004. PMID: 15371104 Free article.

6

A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.

Sun LC, Luo J, Mackey LV, Fuselier JA, Coy DH. Sun LC, et al. Cancer Lett. 2007 Feb 8;246(1-2):157-66. doi: 10.1016/j.canlet.2006.02.016. Epub 2006 Apr 27. Cancer Lett. 2007. PMID: 16644105

7

In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors.

Moody TW, Sun LC, Mantey SA, Pradhan T, Mackey LV, Gonzales N, Fuselier JA, Coy DH, Jensen RT. Moody TW, et al. Among authors: sun lc. J Pharmacol Exp Ther. 2006 Sep;318(3):1265-72. doi: 10.1124/jpet.106.104141. Epub 2006 Jun 9. J Pharmacol Exp Ther. 2006. PMID: 16766720

8

Effects of camptothecin on tumor cell proliferation and angiogenesis when coupled to a bombesin analog used as a targeted delivery vector.

Sun LC, Luo J, Mackey VL, Fuselier JA, Coy DH. Sun LC, et al. Anticancer Drugs. 2007 Mar;18(3):341-8. doi: 10.1097/CAD.0b013e32801261b6. Anticancer Drugs. 2007. PMID: 17264768

9

Somatostatin receptor-targeted anti-cancer therapy.

Sun LC, Coy DH. Sun LC, et al. Curr Drug Deliv. 2011 Jan;8(1):2-10. doi: 10.2174/156720111793663633. Curr Drug Deliv. 2011. PMID: 21034425 Review.

10

Application of human pancreatic carcinoid BON cells for receptor-targeted drug development.

Sun L, Morris LM, Luo J, Mackey LV, Leslie JS, Franko-Tobin LG, Fuselier JA, LePage KT, Coy DH. Sun L, et al. J Drug Target. 2011 Sep;19(8):666-74. doi: 10.3109/1061186X.2010.531728. Epub 2010 Nov 18. J Drug Target. 2011. PMID: 21083509

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,236 results

Search Page

Filters